Top Picks
Show
Browse all public companies recently chosen as top picks by stock experts. Read the daily stock experts opinions and stock predictions.
What is Wealthica?
Signal
Opinion
Expert
TOP PICK
TOP PICK
July 8, 2019
A data center company more geared to investors that want more growth. European data centers. Europe is about 5 years behind the US in data center build out. They have a big runway of growth. Your growth will come from earnings growth. (Analysts’ price target is $81.00)
A data center company more geared to investors that want more growth. European data centers. Europe is about 5 years behind the US in data center build out. They have a big runway of growth. Your growth will come from earnings growth. (Analysts’ price target is $81.00)
TOP PICK
TOP PICK
July 8, 2019
It is a good candidate for environmental social governance investing. It is renewable energy. Assets are in Canada and France. They are guiding to a much stronger pipeline in France than originally anticipated. They are going into solar and battery technology also. (Analysts’ price target is $32.32)
It is a good candidate for environmental social governance investing. It is renewable energy. Assets are in Canada and France. They are guiding to a much stronger pipeline in France than originally anticipated. They are going into solar and battery technology also. (Analysts’ price target is $32.32)
TOP PICK
TOP PICK
July 8, 2019
He focuses on their cable business. Last quarter they had a 10% increase in growth due to pricing as well as subscriber growth. That is the sweet spot. The market is underestimating the transition of the cable business. (Analysts’ price target is $48.09)
He focuses on their cable business. Last quarter they had a 10% increase in growth due to pricing as well as subscriber growth. That is the sweet spot. The market is underestimating the transition of the cable business. (Analysts’ price target is $48.09)
TOP PICK
TOP PICK
July 8, 2019
The market is over-thinking Google. Anti-trust worries have been priced in already. Revenues will grow nearly 20% annually in coming years and they have a ton of cash in the bank. Internet advertising remains unstoppable. Even if the US courts break up the company, there will be more value in the pasts of Google, like self-driving cars. (Analysts’ price target is $1321.89)
The market is over-thinking Google. Anti-trust worries have been priced in already. Revenues will grow nearly 20% annually in coming years and they have a ton of cash in the bank. Internet advertising remains unstoppable. Even if the US courts break up the company, there will be more value in the pasts of Google, like self-driving cars. (Analysts’ price target is $1321.89)
TOP PICK
TOP PICK
July 8, 2019
It has one of the best growth profiles on the street with EPS growth at 10%. It trades at a premium to its peers, though. They have some potential blockbuster drugs focused on diabetes and heart disease. Itt depends on the effectiveness of that drug. Now is a good entry point. (Analysts’ price target is $125.81)
It has one of the best growth profiles on the street with EPS growth at 10%. It trades at a premium to its peers, though. They have some potential blockbuster drugs focused on diabetes and heart disease. Itt depends on the effectiveness of that drug. Now is a good entry point. (Analysts’ price target is $125.81)
TOP PICK
TOP PICK
July 8, 2019
This is more speculative. A legacy legal issue cost them more money than expected which is jeapordizing the yield. All the bad news has been priced in and they should reduce the debt in coming months. The yield should climb to 8%. (Analysts’ price target is $11.88)
This is more speculative. A legacy legal issue cost them more money than expected which is jeapordizing the yield. All the bad news has been priced in and they should reduce the debt in coming months. The yield should climb to 8%. (Analysts’ price target is $11.88)
TOP PICK
TOP PICK
July 5, 2019
He believes in healthcare as a secular play though this sector is a political hot potato. HC's seasonality is about to start, but you really need to hold this long term.
He believes in healthcare as a secular play though this sector is a political hot potato. HC's seasonality is about to start, but you really need to hold this long term.
TOP PICK
TOP PICK
July 5, 2019
Since early spring 2018, it's fallen from $120 to current resistance around $80. It's had a 33% increase in EBITDA. EPS is down a bit from acquisitions, but estimates for 2020 are 48% higher. The CPP Investment Board just bought a big stake. (Analysts’ price target is $90.73)
Since early spring 2018, it's fallen from $120 to current resistance around $80. It's had a 33% increase in EBITDA. EPS is down a bit from acquisitions, but estimates for 2020 are 48% higher. The CPP Investment Board just bought a big stake. (Analysts’ price target is $90.73)
TOP PICK
TOP PICK
July 5, 2019
A new ETF launched September last year. Sustainable investing from an international perspective. Incredibly low MER at 0.15%. Gets rid of weapons and tobacco, and pure play fossil fuels companies like Shell or BP, which would not be included. However it does include pipelines and mining companies. Has outperformed the traditional Vanguard S&P 500 XUS ETF.
A new ETF launched September last year. Sustainable investing from an international perspective. Incredibly low MER at 0.15%. Gets rid of weapons and tobacco, and pure play fossil fuels companies like Shell or BP, which would not be included. However it does include pipelines and mining companies. Has outperformed the traditional Vanguard S&P 500 XUS ETF.
TOP PICK
TOP PICK
July 5, 2019
Just launched earlier this year. One of the first socially responsible bond ETFs. Very low MER at 0.18%. Interestingly most of the socially responsible ETFs screen out alcohol but this one doesn't. Exposure to both government and to corporate bonds.
Just launched earlier this year. One of the first socially responsible bond ETFs. Very low MER at 0.18%. Interestingly most of the socially responsible ETFs screen out alcohol but this one doesn't. Exposure to both government and to corporate bonds.
TOP PICK
TOP PICK
July 5, 2019
Under the umbrella of Brookfield they are going to have no problem raising money. Did their first green bonds a little while ago. Just did a 50% stake acquisition in a Spanish solar company that owns solar projects. The gold standard when it comes to renewable energy utilities. Probably the largest from a market cap perspective. Dividend 5.82% plus room to grow with access to capital through Brookfield. (Analysts’ price target is $44.60)
Under the umbrella of Brookfield they are going to have no problem raising money. Did their first green bonds a little while ago. Just did a 50% stake acquisition in a Spanish solar company that owns solar projects. The gold standard when it comes to renewable energy utilities. Probably the largest from a market cap perspective. Dividend 5.82% plus room to grow with access to capital through Brookfield. (Analysts’ price target is $44.60)
TOP PICK
TOP PICK
July 5, 2019
They've done a really good job on recurring revenue. Fantastic balance sheet. Street consensus is BUY. Price target : $60.64
They've done a really good job on recurring revenue. Fantastic balance sheet. Street consensus is BUY. Price target : $60.64
TOP PICK
TOP PICK
July 4, 2019
It has great assets in BC. It has no debt and a famous investor owns 30 percent of it. TECK.B-T may move their volumes to a terminal that they co-own next March. He thinks they can't move all of their volume. They have the ability to increase their dividend and they have no debt. (Analysts’ price target is $25.38)
It has great assets in BC. It has no debt and a famous investor owns 30 percent of it. TECK.B-T may move their volumes to a terminal that they co-own next March. He thinks they can't move all of their volume. They have the ability to increase their dividend and they have no debt. (Analysts’ price target is $25.38)
TOP PICK
TOP PICK
July 4, 2019
The US is talking about having Medicare for all. This company does a good job of eliminating cost for all involved. They raised the dividend over the last few years. He sees it as a good solid company. (Analysts’ price target is $287.80)
The US is talking about having Medicare for all. This company does a good job of eliminating cost for all involved. They raised the dividend over the last few years. He sees it as a good solid company. (Analysts’ price target is $287.80)
TOP PICK
TOP PICK
July 4, 2019
This little company has growth around the world. The next leg of growth may be in Europe. 70 percent of revenue comes from food. Now they are focusing more on purchasing and making acquisitions. The next leg of growth could be Asia. They get good margins on their car washes. It should continue to grow. They want to double in 5 years. (Analysts’ price target is $85.13)
This little company has growth around the world. The next leg of growth may be in Europe. 70 percent of revenue comes from food. Now they are focusing more on purchasing and making acquisitions. The next leg of growth could be Asia. They get good margins on their car washes. It should continue to grow. They want to double in 5 years. (Analysts’ price target is $85.13)
